Guardant Health (NASDAQ: GH) affiliate files Rule 144 notice for planned share resales

Rhea-AI Filing Summary

Guardant Health, Inc. (GH) reported proposed resale transactions under Rule 144 by an affiliate. The filing lists planned restricted-stock-related sales of 80 shares with a 12/15/2025 lapse date and 36 shares with a 02/15/2026 lapse date. The filing also records recent sales by Musa Tariq of 348 shares (03/18/2026) and 116 shares (04/16/2026).

Insights

Securities Compliance Attorney

Rule 144 notices document intended resale of restricted shares by an affiliate.

These entries show planned sales tied to restricted stock lapses (12/15/2025 and 02/15/2026) and prior open-market dispositions by Musa Tariq on 03/18/2026 and 04/16/2026. The filing lists exact share counts and transaction dates.

Timing and proceeds mechanics are not detailed beyond the listed dates and amounts. Subsequent SEC filings or broker reports would show whether the planned sales were executed.

Key Figures

Planned resale (12/15/2025): 80 shares Planned resale (02/15/2026): 36 shares Recorded sale (03/18/2026): 348 shares +3 more

6 metrics

Planned resale (12/15/2025) 80 shares restricted stock lapse 12/15/2025

Planned resale (02/15/2026) 36 shares restricted stock lapse 02/15/2026

Recorded sale (03/18/2026) 348 shares sale by Musa Tariq on 03/18/2026

Recorded sale (04/16/2026) 116 shares sale by Musa Tariq on 04/16/2026

Broker details (listed) Charles Schwab & Co., Inc. broker name and address provided

Numeric entry from header 132599929 numeric value appearing on the cover lines

Key Terms

Rule 144, restricted stock lapse, Form 144

3 terms

Rule 144 regulatory

"reported proposed resale transactions under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock lapse financial

"Restricted Stock Lapse -check lots/dates"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	116	11131.00	132599929	05/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/15/2025	Restricted Stock Lapse -check lots/dates	Guardant Health, Inc.			80	12/15/2025	Equity Compensation
Common	02/15/2026	Restricted Stock Lapse -check lots/dates	Guardant Health, Inc.			36	02/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	03/18/2026	348	30655.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	04/16/2026	116	9840.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)